Skip to main content
. 2014 Jan;14(1):69–95. doi: 10.2174/15665240113136660079

Table 2.

Quantitative Immunoassays for the Detection of Autoantibodies in Autoimmune Blistering Skin Diseases

Autoantigen Epitope(s) Disease(s) Commercially
Available
References
Desmoglein 1 Ectodomain Pemphigus yes [26, 178]
Desmoglein 3 Ectodomain Pemphigus yes [26, 178]
Envoplakin Full-length Paraneoplastic pemphigus yes [179-181]
Periplakin Full-length Paraneoplastic pemphigus no [179, 180]
BP180/collagen XVII NC16A domain Pemphigoid (IgG, IgE) yes [92, 95, 182-184]
  4xNC16A domain Pemphigoid (IgG) yes [62]
  Ectodomain Pemphigoid (IgA) no [138]
BP230 Fragments covering the full-lenght of BP230 Pemphigoid (IgG) yes [93]
Laminin Γ1 (p200) C-terminal regiÓn Anti-p200 pemphigoid (IgG) no [150]
Collagen VII NC1 domain Epidermolysis bullosa acquisita (IgG) yes [185, 186]
  NC1, NC2 domains Epidermolysis bullosa acquisita (IgG) yes [159]
  NC1, NC2, hinge domains Epidermolysis bullosa acquisita (IgG) no [161]
Transglutaminase,
tissue
Full-length Dermatitis herpetiformis (IgA) yes [166, 187]
Transglutaminase,
tissue
Deamidated gliadin-analogous fusion peptides Dermatitis herpetiformis (IgA) yes [188]
Transglutaminase,
epidermal
  Dermatitis herpetiformis (IgA) yes [167]